Loading clinical trials...
Loading clinical trials...
A Phase 2 Randomized Study to Compare the Efficacy and Safety of Ultrasonic Drug Delivery to Standard of Care for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Chronic Non-Healing Wounds
Conditions
Interventions
Ultrasonic Drug Delivery
Standard of Care Antibiotic Treatment
Start Date
February 1, 2019
Primary Completion Date
January 31, 2020
Completion Date
July 31, 2020
Last Updated
November 6, 2018
NCT00777712
NCT04450693
NCT05921292
NCT06442865
NCT06394518
NCT04240574
Lead Sponsor
Sonescence, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions